News
The Fogarty International Center within the National Institutes of Health has had a huge global footprint and impact. US ...
On August 7, President Trump signed an executive order that could fundamentally restructure how federal research grants are ...
Standard BioTools Inc. (NASDAQ: LAB) (the "Company" or "Standard BioTools") today announced financial results for the second quarter ended ...
Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Good afternoon, and welcome to the PacBio Second Quarter 2025 ...
Portal Innovations this morning announced a $100 million fund that will focus on fueling research out of universities that result in early-stage biotech and medtech startups, a deliberate move by the ...
Strong organic growth and doubled operating profit in the enzyme business April - June 2025Net sales totaled SEK 28,871 (24,601)* thousand, with a growth rate of 17 %, 28 % when adjusted for currency ...
The prestigious St. Louis institution grapples with fewer grants and millions less in funding, yet recent developments on ...
As federal support vanishes for research addressing the root causes of health disparities in the United States, we are left ...
U.S. President Donald Trump signed a new executive order that changes how the U.S. government awards research grants and ...
UC San Diego's School of Medicine awarded grants to 17 biomedical research projects, supported by a $1 million gift from ...
After one of the strongest earthquakes in recorded history grunted and shifted off the coast of Russia, geologists sent ...
StockStory.org on MSN19h
CRL Q2 Deep Dive: Flat Sales and Margin Pressures Offset by Demand Stabilization and Raised Outlook
Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results , but sales were flat year on year at $1.03 billion. Its non-GAAP profit of $3.12 per share was 24.6% above ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results